Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, et al. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells. BMC Cancer. 2015;15:726 pubmed publisher

Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, et al. Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncol Rep. 2015;34:504-10 pubmed publisher

Huang C, Park Y, Lin H, Pathania D, Park K, Avila Wallace M, et al. Compact and Filter-Free Luminescence Biosensor for Mobile in Vitro Diagnoses. ACS Nano. 2019;13:11698-11706 pubmed publisher

Huerta Nuñez L, Gutiérrez Iglesias G, Martínez Cuazitl A, Mata Miranda M, Alvarez Jiménez V, Sánchez Monroy V, et al. A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy. Sci Rep. 2019;9:6419 pubmed publisher

Hutt M, Fellermeier Kopf S, Seifert O, Schmitt L, Pfizenmaier K, Kontermann R. Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells. Oncotarget. 2018;9:11322-11335 pubmed publisher